We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$203B
AUM Growth
+$28.4B
Cap. Flow
+$14B
Cap. Flow %
6.91%
Top 10 Hldgs %
26.11%
Holding
7,181
New
870
Increased
2,213
Reduced
2,337
Closed
1,192

Sector Composition

Rank Sector Weight
1 Technology 8.38%
2 Healthcare 7.46%
3 Consumer Discretionary 5.14%
4 Industrials 5.11%
5 Financials 4.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARBGW
5751
CALL
DELISTED
Aequi Acquisition Corp warrants
ARBGW
$6.7K ﹤0.01%
266,972
IPVF.WS
5752
CALL
DELISTED
InterPrivate III Financial Partners Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
IPVF.WS
$6.68K ﹤0.01%
136,661
CEROW
5753
CALL
DELISTED
CERo Therapeutics Warrants
CEROW
$6.64K ﹤0.01%
108,750
PRSO icon
5754
Peraso
PRSO
$10.1M
$6.6K ﹤0.01%
+333
New +$6.71K
SABSW icon
5755
CALL
SAB Biotherapeutics Warrant
SABSW
$371K
$6.53K ﹤0.01%
62,500
VIEWW
5756
CALL
DELISTED
View, Inc. Warrant
VIEWW
$6.49K ﹤0.01%
564,108
TWLVW
5757
CALL
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$6.48K ﹤0.01%
102,805
ICU icon
5758
SeaStar Medical
ICU
$14.5M
$6.44K ﹤0.01%
+49
New +$14.7K
MTNB icon
5759
Matinas BioPharma
MTNB
$2.96M
$6.4K ﹤0.01%
356
-3,883
-92% -$90.5K
SUNL.WS
5760
CALL
DELISTED
Sunlight Financial Holdings, Inc. Warrants, exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SUNL.WS
$6.37K ﹤0.01%
376,613
-641,202
-63% -$21.5K
NVACR
5761
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$6.3K ﹤0.01%
45,000
RBT.WS
5762
CALL
DELISTED
Rubicon Technologies, Inc. Warrants, each warrant is exercisable for 1/8th of a share of Class A Common Stock at an exercise price of $92.00r share
RBT.WS
$6.26K ﹤0.01%
350,000
-598,825
-63% -$16.9K
SDACW
5763
CALL
DELISTED
Sustainable Development Acquisition I Corp. Warrant
SDACW
$6.21K ﹤0.01%
207,000
TCON
5764
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$6.16K ﹤0.01%
1,058
+470
+80% +$8.59K
NKGNW
5765
CALL
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
$6.14K ﹤0.01%
30,698
-18,580
-38% -$3.27K
AUUD
5766
Auddia
AUUD
$5.7M
$6.13K ﹤0.01%
+5
New +$8.16K
DXF
5767
Eason Technology Ltd
DXF
$1.59M
$6K ﹤0.01%
+34
New +$7.39K
ZINGW
5768
CALL
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$6K ﹤0.01%
300,000
CFIVW
5769
CALL
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$5.92K ﹤0.01%
93,413
ENERR
5770
DELISTED
Accretion Acquisition Corp Right
ENERR
$5.86K ﹤0.01%
54,000
YOTAW
5771
CALL
DELISTED
Yotta Acquisition Corporation Warrant
YOTAW
$5.76K ﹤0.01%
100,000
HUBC icon
5772
Hub Cyber Security
HUBC
$24M
0
ELYS
5773
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$5.71K ﹤0.01%
14,887
-9,895
-40% -$4.87K
IRNT
5774
DELISTED
IronNet, Inc.
IRNT
$5.7K ﹤0.01%
27,333
-5,525
-17% -$1.37K
BCSAW
5775
CALL
DELISTED
Blockchain Coinvestors Acquisition Corp. I Warrant
BCSAW
$5.67K ﹤0.01%
101,650

Similar funds

Israel Englander's Q2 2023 Portfolio in Review

As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.

By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.

  • Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
  • Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
  • Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
  • Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
  • Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
  • Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
  • Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.